Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company. It operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The company develops, manufactures, and markets products primarily in the therapeutic areas of gastroenterology, hepatology, neurology and dermatology, generic and branded generic pharmaceuticals, dentistry products, over-the-counter products, aesthetic medical devices, and eye health. The company sells its products in the United States, China, Canada, Poland, Mexico, France, South Korea, Russia, Japan, Germany, the United Kingdom, Spain, Italy, and internationally. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada. Show more

2150 St. Elzéar Blvd. West, Laval, QC, H7L 4A8, Canada

Drug Manufacturers - Specialty & Generic
Healthcare

Market Cap

2.103B

52 Wk Range

$4.41 - $8.69

Previous Close

$5.54

Open

$5.62

Volume

1,335,657

Day Range

$5.49 - $5.63

Enterprise Value

21.64B

Cash

1.309B

Avg Qtr Burn

N/A

Insider Ownership

30.41%

Institutional Own.

65.74%

Qtr Updated

12/31/25


Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date